Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa JA, Magnano L, Rivero A, Rivas-Delgado A, Nadeu F, Correa JG, Giné E, Villamor N, Filella X, Colomer D, López M, López-Oreja I, Costa D, Aymerich M, Beà S, López-Guillermo A, Campo E, Delgado J, Mozas P.
Piñeyroa JA, et al.
Hematol Oncol. 2022 Oct;40(4):588-595. doi: 10.1002/hon.3027. Epub 2022 May 28.
Hematol Oncol. 2022.
PMID: 35611996